A new study from the Keck School of Medicine at USC has found that proteins linked to inflammation may play a role in bone ...

Alendronate has been shown to increase bone mineral density (BMD) and decrease fracture risk in postmenopausal women with osteoporosis, but the need for long-term treatment is unclear, especially ...

Osteoporosis is a medical condition in which new calcium deposits in bone tissue cannot keep up with old bone calcium removal. It plagues over 61 million people in India, with 80% being women. In 2015 ...

The global osteoporosis drugs market size was valued at USD 14.90 billion in 2024 and is projected to reach USD 15.39 billion ...

Implementing opportunistic computed tomography (CT) bone density screening could increase the osteoporosis screening rate, yielding a reduction in medical costs.

Should you take a calcium supplement? And if so, how much? Here's what to know about calcium's benefits and some warnings.

A new study published in the journal of BMC Gasteroenterology found that patients with the liver cirrhosis had higher risk of ...

Some 10 million Americans over age 50 have the weak and brittle bones of osteoporosis — and an additional 44 million have osteopenia (meaning a lower than normal bone density), according to the ...

The "Osteoporosis_Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report provides an overview of Osteoporosis Clinical ...

The FDA approved Stoboclo and Osenvelt, denosumab biosimilars that could offer more affordable treatment options for ...

The FDA has approved Stoboclo (denosumab-bmwo), a biosimilar to Prolia (denosumab), and Osenvelt (denosumab-bmwo), a biosimilar to Xgeva (denosumab).